Skip to main content

Articles

Real talk about Ozempic, Zepbound, and what happens when insurance says no.

About

·1 min
💉

Insurance Said No. I Found Another Way.

This site exists because I went through the same frustrating process you're going through now.

15+
Platforms Researched
20+
Guides Written
100%
Independent

The Short Version

I lost insurance coverage for my GLP-1 medication. The weight came back. I spent weeks researching alternatives — telehealth platforms, compounded medications, self-pay options, insurance appeals.

Denied a GLP-1 for PCOS or Fertility Issues? Here's What You Need to Know

·7 mins

Denied a GLP-1 for PCOS or Fertility?

Women with PCOS and fertility struggles are seeing results with GLP-1 medications — but many are still being denied coverage. Here's what you need to know.

Best Telehealth for GLP-1 Prescriptions Without Insurance (2026)

·7 mins
Last reviewed: January 25, 2026
How I chose these →
💡 Skip the insurance fight. These telehealth platforms connect you with licensed providers who prescribe compounded GLP-1 medications — delivered to your door, no insurance needed.
✍️
Written by someone who's been through it. I've personally used telehealth for GLP-1s after my insurance denied coverage. This guide is based on real research and experience.

Platform Comparison

PlatformStarting PriceMedicationBest For
🏆 Eden Health$129/mo first month (sema)Compounded semaglutide & tirzepatideMoney-back warranty, 127k+ members, FSA/HSA eligible
💰 Sprout Health$150 off first monthCompounded semaglutide & tirzepatideBest first-month deal, no hidden fees, price lock
MyStart Health$299/mo (before discounts)Compounded semaglutide & tirzepatide$150 off + 25% lifetime discount, 600+ doctors
Elevate Health$200 off tirzepatideCompounded tirzepatideFree blood work, payment plans (Klarna, Afterpay, Affirm)

All platforms include: Licensed provider consultation, prescription, medication shipped to your door. No insurance required.

GLP-1 Comparison Guide: Semaglutide vs Tirzepatide, Brand vs Compounded (2026)

·8 mins

⚡ The Short Answer

Tirzepatide is slightly more effective (~20-22% weight loss vs ~15-17% for semaglutide). Semaglutide is more affordable and accessible through telehealth ($129-300/mo). Brand-name and compounded versions contain the same active ingredients — the difference is price and packaging. For most people, semaglutide via telehealth is the best starting point.

GLP-1s and Hashimoto's: How Semaglutide Helped When Nothing Else Worked

·10 mins

⚡ The Short Answer

Yes, you can take GLP-1 medications like semaglutide and tirzepatide if you have Hashimoto's or hypothyroidism. They're safe to use alongside levothyroxine, and research shows they may actually improve TSH levels as you lose weight. I have Hashimoto's — GLP-1s finally helped me lose weight when nothing else worked.

PCOS and GLP-1s: Can Ozempic or Wegovy Help When Nothing Else Works?

·12 mins

⚡ The Short Answer

Yes, you can take GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound if you have PCOS. Research shows ~80% of women with PCOS who take semaglutide lose at least 5% of their body weight — and that weight loss improves insulin resistance, menstrual regularity, and potentially fertility. GLP-1s address the root metabolic issues that make PCOS weight loss so difficult.

GLP-1 Pills vs Injections: Which Is Better for Weight Loss? (2026)

·10 mins
✍️
Why I wrote this: When I started researching GLP-1s, I assumed I'd have to do weekly injections. Turns out there's a pill option — but figuring out how it compares took some digging. Here's what I found.

If you’re needle-averse (no judgment — many people are), you might be wondering: is there a GLP-1 pill? And if so, is it as effective as the injections everyone’s talking about?

What Is Retatrutide? The Next-Gen Weight Loss Drug Explained (2026)

·9 mins

⚠️ Important: Retatrutide Is Not Yet Available

Retatrutide is still in clinical trials and is not FDA-approved. It cannot be legally prescribed or purchased outside of research studies. Any website selling "retatrutide" or "research peptides" is selling an unregulated, potentially dangerous product. FDA approval is expected in late 2026 or 2027.